Pac Premier
Giving Guide
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Study results modest for Sienna psoriasis treatment

By   /   Monday, August 27th, 2018  /   Comments Off on Study results modest for Sienna psoriasis treatment

    Print       Email
An exploratory study of a product in Sienna Biopharmaceuticals’ Topical By Design platform showed modest results for psoriasis patients who used the therapy for 10 days. Subjects who applied the topical medication as part of the 15-person, double-blind study did not see a significant reduction in inflammation, but the test did show a “modulation” of…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email